Hamill John P.

EDGAR CIK 0001716213

Aprea Therapeutics, Inc. - APRE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
SrVP/CFO/Prin Fin & Acct Ofcr
Direct Buys
3
$8,661
1,510 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/11/2024
10/16/2024
Buy
50 @ $2.46
 $123 19,368 (0.26%) Direct
10/10/2024
10/15/2024
Buy
450 @ $2.61
 $1,174 19,318 (2.38%) Direct
03/13/2024
03/14/2024
Buy
1,010 @ $7.29
 $7,363 15,503 (6.97%) Direct